1-(1H-Imidazol-1-yl)ethanone → HCID 22724269, compound
Reaction equation
Br[CH2:2][C:3]1[C:8](=[O:9])[N:7]([C:10]2[CH:15]=[CH:14][CH:13]=[C:12]([N:16]3[C:20](=[O:21])[CH2:19][CH2:18][C:17]3=[O:22])[CH:11]=2)[C:6]2[N:23]=[CH:24][CH:25]=[CH:26][C:5]=2[N:4]=1.C([N:30]1[CH:34]=[CH:33][N:32]=[CH:31]1)(=O)C>C(#N)C>[NH:30]1[CH:34]=[CH:33][N:32]=[C:31]1[CH2:2][C:3]1[C:8](=[O:9])[N:7]([C:10]2[CH:15]=[CH:14][CH:13]=[C:12]([N:16]3[C:20](=[O:21])[CH2:19][CH2:18][C:17]3=[O:22])[CH:11]=2)[C:6]2[N:23]=[CH:24][CH:25]=[CH:26][C:5]=2[N:4]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 2-(bromomethyl)-4-(3-succinimidophenyl)-3-oxo-3,4-dihydropyrido[2,3-b]pyrazine (420 mg) in acetonitrile (4 ml) was added 1-acetylimidazole (179 mg). The solution was refluxed for an hour. The mixture was evaporated. The residue was dissolved in water, and to the solution was added sodium carbonate. The mixture was extracted by ethyl acetate. The organic layer was evaporated. The residue was purified by column chromatography to obtain 2-(1-imidazolylmethyl)-4-(3-succinimidophenyl)-3-oxo-3,4-dihydropyrido[2,3-b]pyrazine (105 mg) as yellow powder.
Workup
- temperatureThe solution was refluxed for an hour
- customThe mixture was evaporated
- dissolutionThe residue was dissolved in water
- additionto the solution was added sodium carbonate
- extractionThe mixture was extracted by ethyl acetate
- customThe organic layer was evaporated
- customThe residue was purified by column chromatography
Sources & evidence
- ORD record
- ord-35508f66790e4970aa673f823c9b0de3
- Source dataset
- uspto-grants-2004_04
- Patent number
- US06727245B2
Reaction notes
Loading…